

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.99650054 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.99650054 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.52926292 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.32060231 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.62933624 |
| 6 | response to type I interferon (GO:0034340) | 4.84953990 |
| 7 | type I interferon signaling pathway (GO:0060337) | 4.78699773 |
| 8 | cellular response to type I interferon (GO:0071357) | 4.78699773 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.72448546 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.60743705 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.49780305 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.42491145 |
| 13 | detection of bacterium (GO:0016045) | 4.33761991 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 4.30674917 |
| 15 | response to interferon-beta (GO:0035456) | 4.28908880 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 4.28530148 |
| 17 | detection of other organism (GO:0098543) | 4.27413500 |
| 18 | definitive hemopoiesis (GO:0060216) | 4.10676222 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.03981065 |
| 20 | response to interferon-alpha (GO:0035455) | 4.01825681 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.00669368 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.93285514 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.84787377 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 3.80924159 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.79819528 |
| 26 | megakaryocyte development (GO:0035855) | 3.79083088 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.76016796 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.76016796 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.75717106 |
| 30 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.65528280 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.63321195 |
| 32 | cellular response to interferon-beta (GO:0035458) | 3.61714642 |
| 33 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.61603438 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.58276039 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.57760291 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.56874243 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.56088416 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.54083000 |
| 39 | negative T cell selection (GO:0043383) | 3.49867114 |
| 40 | defense response to protozoan (GO:0042832) | 3.48874864 |
| 41 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.45764362 |
| 42 | T cell migration (GO:0072678) | 3.44365990 |
| 43 | positive T cell selection (GO:0043368) | 3.43403119 |
| 44 | negative regulation of viral genome replication (GO:0045071) | 3.40623887 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.40611270 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40608994 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.40000280 |
| 48 | cellular extravasation (GO:0045123) | 3.39417814 |
| 49 | regulation of interferon-alpha production (GO:0032647) | 3.37254991 |
| 50 | mature B cell differentiation (GO:0002335) | 3.34784234 |
| 51 | response to protozoan (GO:0001562) | 3.31924263 |
| 52 | response to interleukin-15 (GO:0070672) | 3.29903652 |
| 53 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.29494962 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 3.29222302 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.27843162 |
| 56 | positive thymic T cell selection (GO:0045059) | 3.27798761 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26603269 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.24267205 |
| 59 | mature B cell differentiation involved in immune response (GO:0002313) | 3.21670103 |
| 60 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18953255 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 3.18915606 |
| 62 | response to host immune response (GO:0052572) | 3.14677465 |
| 63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14677465 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 3.10687657 |
| 65 | T cell homeostasis (GO:0043029) | 3.10508847 |
| 66 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.10172693 |
| 67 | regulation of RIG-I signaling pathway (GO:0039535) | 3.08615116 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07765724 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07125966 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.05177403 |
| 71 | microglial cell activation (GO:0001774) | 3.00486971 |
| 72 | regulation of response to interferon-gamma (GO:0060330) | 2.99663489 |
| 73 | neutrophil activation (GO:0042119) | 2.99461971 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 2.98571768 |
| 75 | detection of biotic stimulus (GO:0009595) | 2.98149578 |
| 76 | negative regulation of innate immune response (GO:0045824) | 2.97827834 |
| 77 | lymph node development (GO:0048535) | 2.96494417 |
| 78 | response to host (GO:0075136) | 2.94218460 |
| 79 | response to host defenses (GO:0052200) | 2.94218460 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.94218460 |
| 81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.93871440 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 2.90045544 |
| 83 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89153343 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.89024868 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 2.88729080 |
| 86 | regulation of erythrocyte differentiation (GO:0045646) | 2.88584963 |
| 87 | cellular response to exogenous dsRNA (GO:0071360) | 2.88151457 |
| 88 | B cell mediated immunity (GO:0019724) | 2.87802955 |
| 89 | regulation of regulatory T cell differentiation (GO:0045589) | 2.87486772 |
| 90 | positive regulation of interferon-beta production (GO:0032728) | 2.87296679 |
| 91 | response to muramyl dipeptide (GO:0032495) | 2.87235477 |
| 92 | respiratory burst (GO:0045730) | 2.86471552 |
| 93 | cellular response to interleukin-15 (GO:0071350) | 2.86027150 |
| 94 | lymphocyte homeostasis (GO:0002260) | 2.84577369 |
| 95 | mast cell activation (GO:0045576) | 2.84201804 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.82911048 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82456771 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82456771 |
| 99 | negative regulation of phagocytosis (GO:0050765) | 2.82029453 |
| 100 | positive regulation of humoral immune response (GO:0002922) | 2.81777320 |
| 101 | tolerance induction (GO:0002507) | 2.81761800 |
| 102 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.81725749 |
| 103 | platelet dense granule organization (GO:0060155) | 2.80794456 |
| 104 | positive regulation of type 2 immune response (GO:0002830) | 2.80644058 |
| 105 | thymic T cell selection (GO:0045061) | 2.78308604 |
| 106 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.76843988 |
| 107 | embryonic hemopoiesis (GO:0035162) | 2.76790140 |
| 108 | leukocyte degranulation (GO:0043299) | 2.76776911 |
| 109 | regulation of natural killer cell differentiation (GO:0032823) | 2.76257765 |
| 110 | leukocyte aggregation (GO:0070486) | 2.74614021 |
| 111 | interferon-gamma production (GO:0032609) | 2.73889511 |
| 112 | granulocyte activation (GO:0036230) | 2.73363342 |
| 113 | regulation of antigen processing and presentation (GO:0002577) | 2.72909873 |
| 114 | leukocyte homeostasis (GO:0001776) | 2.72319933 |
| 115 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71574830 |
| 116 | modulation by symbiont of host defense response (GO:0052031) | 2.71574830 |
| 117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71574830 |
| 118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71574830 |
| 119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71574830 |
| 120 | modulation by symbiont of host immune response (GO:0052553) | 2.71574830 |
| 121 | Peyers patch development (GO:0048541) | 2.71376493 |
| 122 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.71376493 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.70670951 |
| 124 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.70588358 |
| 125 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.68454045 |
| 126 | T cell selection (GO:0045058) | 2.65788120 |
| 127 | response to peptidoglycan (GO:0032494) | 2.64979041 |
| 128 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64768945 |
| 129 | dendritic cell differentiation (GO:0097028) | 2.63949262 |
| 130 | positive regulation of defense response to virus by host (GO:0002230) | 2.63528810 |
| 131 | positive regulation of granulocyte differentiation (GO:0030854) | 2.60913820 |
| 132 | cellular response to interferon-gamma (GO:0071346) | 2.60448367 |
| 133 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.60345295 |
| 134 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.60173017 |
| 135 | B cell homeostasis (GO:0001782) | 2.59020301 |
| 136 | positive regulation of isotype switching (GO:0045830) | 2.58394536 |
| 137 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.58357364 |
| 138 | positive regulation of natural killer cell activation (GO:0032816) | 2.55616883 |
| 139 | viral transcription (GO:0019083) | 2.55293637 |
| 140 | germinal center formation (GO:0002467) | 2.55052486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.83822412 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.34381172 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92422610 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.79893536 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.76873704 |
| 6 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.75694093 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72978928 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.65246484 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41150716 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.34563264 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.93790974 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72964131 |
| 13 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71715030 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61073803 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.60279488 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.53352753 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51423156 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51116008 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.50554179 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.49098649 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46098634 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36281083 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.34565393 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.30886061 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.26374638 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22589460 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19588975 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.10337858 |
| 29 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10329217 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04752899 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00538551 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99894330 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98819570 |
| 34 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98089864 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91000504 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.90377222 |
| 37 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86606499 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86513094 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83252032 |
| 40 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82630082 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79086454 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77175221 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76817527 |
| 44 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.76801898 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.74366973 |
| 46 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.69173556 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.69169748 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.66111043 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64818679 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64321644 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.63844399 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62603778 |
| 53 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.56089621 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53840795 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47852732 |
| 56 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47258275 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.46578423 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41790020 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38933575 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35939408 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35096391 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34892416 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31760675 |
| 64 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28626010 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26566506 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25472790 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25453302 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24105243 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23467715 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23229520 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22093725 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21852570 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19841604 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18545581 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17691576 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16952247 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16462110 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13762442 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11719575 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10174550 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09264495 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06796988 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06638257 |
| 84 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.06341365 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05600571 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03880199 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03053754 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98548771 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97494817 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97361260 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95035775 |
| 92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95025021 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94507332 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94269241 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93872970 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93788907 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 0.92446666 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92248880 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91989267 |
| 100 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90813040 |
| 101 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.90611329 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.88493257 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86595329 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86511533 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85952261 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85289944 |
| 107 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.84888721 |
| 108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84865036 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84311979 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83515659 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79613077 |
| 112 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77797703 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77060307 |
| 114 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75166911 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.69264335 |
| 116 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69006166 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.67949575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.29744715 |
| 2 | MP0000685_abnormal_immune_system | 3.47141739 |
| 3 | MP0005671_abnormal_response_to | 3.21802440 |
| 4 | MP0009785_altered_susceptibility_to | 3.17707820 |
| 5 | MP0001800_abnormal_humoral_immune | 2.93234075 |
| 6 | MP0005387_immune_system_phenotype | 2.83759310 |
| 7 | MP0001790_abnormal_immune_system | 2.83759310 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.81616624 |
| 9 | MP0005025_abnormal_response_to | 2.72788122 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.67722482 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.62005494 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.59923400 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.58538069 |
| 14 | MP0003436_decreased_susceptibility_to | 2.58077083 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.58052432 |
| 16 | MP0002723_abnormal_immune_serum | 2.57232998 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.47681488 |
| 18 | MP0001819_abnormal_immune_cell | 2.46301806 |
| 19 | MP0002398_abnormal_bone_marrow | 2.41806187 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.38076038 |
| 21 | MP0004510_myositis | 2.36163642 |
| 22 | MP0002419_abnormal_innate_immunity | 2.33459282 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 2.26478331 |
| 24 | MP0003724_increased_susceptibility_to | 2.22463783 |
| 25 | MP0001873_stomach_inflammation | 2.13634705 |
| 26 | MP0000716_abnormal_immune_system | 2.13125278 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.10917389 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.10917389 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.05525151 |
| 30 | MP0006082_CNS_inflammation | 1.96862934 |
| 31 | MP0002006_tumorigenesis | 1.96402879 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.93729534 |
| 33 | MP0002722_abnormal_immune_system | 1.93089710 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.92319446 |
| 35 | MP0002405_respiratory_system_inflammati | 1.88831844 |
| 36 | MP0002429_abnormal_blood_cell | 1.88285176 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.86842345 |
| 38 | MP0004947_skin_inflammation | 1.85400837 |
| 39 | MP0009278_abnormal_bone_marrow | 1.80706318 |
| 40 | MP0001853_heart_inflammation | 1.75272336 |
| 41 | MP0004147_increased_porphyrin_level | 1.72742789 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.71586442 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.71534994 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.63524017 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.56567543 |
| 46 | MP0003303_peritoneal_inflammation | 1.53978514 |
| 47 | MP0008469_abnormal_protein_level | 1.52656759 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.50692617 |
| 49 | MP0003866_abnormal_defecation | 1.44981771 |
| 50 | MP0005310_abnormal_salivary_gland | 1.43356657 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.40156935 |
| 52 | MP0008260_abnormal_autophagy | 1.37202552 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.35782974 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.26774458 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.25940857 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.25375155 |
| 57 | MP0000490_abnormal_crypts_of | 1.24908891 |
| 58 | MP0008004_abnormal_stomach_pH | 1.22810623 |
| 59 | MP0009764_decreased_sensitivity_to | 1.18137556 |
| 60 | MP0002933_joint_inflammation | 1.13048656 |
| 61 | MP0002095_abnormal_skin_pigmentation | 1.13032260 |
| 62 | MP0004883_abnormal_blood_vessel | 1.09218062 |
| 63 | MP0000343_altered_response_to | 1.06392279 |
| 64 | MP0003448_altered_tumor_morphology | 1.05600624 |
| 65 | MP0000858_altered_metastatic_potential | 1.03493030 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.00383028 |
| 67 | MP0005451_abnormal_body_composition | 0.97973607 |
| 68 | MP0005390_skeleton_phenotype | 0.97923434 |
| 69 | MP0009763_increased_sensitivity_to | 0.96652056 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 0.95242584 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.94255220 |
| 72 | MP0006054_spinal_hemorrhage | 0.93986389 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 0.93257691 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 0.91710912 |
| 75 | MP0002019_abnormal_tumor_incidence | 0.91324275 |
| 76 | MP0005360_urolithiasis | 0.90280885 |
| 77 | MP0005164_abnormal_response_to | 0.90253630 |
| 78 | MP0000604_amyloidosis | 0.88072515 |
| 79 | MP0003828_pulmonary_edema | 0.80690431 |
| 80 | MP0002009_preneoplasia | 0.80356826 |
| 81 | MP0003279_aneurysm | 0.79539207 |
| 82 | MP0001851_eye_inflammation | 0.77505801 |
| 83 | MP0003943_abnormal_hepatobiliary_system | 0.77324638 |
| 84 | MP0002132_abnormal_respiratory_system | 0.76341244 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.75884477 |
| 86 | MP0004381_abnormal_hair_follicle | 0.74660540 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.74622966 |
| 88 | MP0009840_abnormal_foam_cell | 0.73834222 |
| 89 | MP0003690_abnormal_glial_cell | 0.72977592 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.72327954 |
| 91 | MP0003091_abnormal_cell_migration | 0.70923705 |
| 92 | MP0000371_diluted_coat_color | 0.70184272 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.69883812 |
| 94 | MP0003795_abnormal_bone_structure | 0.69782055 |
| 95 | MP0010307_abnormal_tumor_latency | 0.69610158 |
| 96 | MP0000249_abnormal_blood_vessel | 0.69597026 |
| 97 | MP0003252_abnormal_bile_duct | 0.69300768 |
| 98 | MP0002254_reproductive_system_inflammat | 0.68431257 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.68391586 |
| 100 | MP0005381_digestive/alimentary_phenotyp | 0.67387411 |
| 101 | MP0001958_emphysema | 0.66671008 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.66373164 |
| 103 | MP0005166_decreased_susceptibility_to | 0.65860460 |
| 104 | MP0000598_abnormal_liver_morphology | 0.65610549 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.63659708 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.63643823 |
| 107 | MP0000609_abnormal_liver_physiology | 0.63098340 |
| 108 | MP0001663_abnormal_digestive_system | 0.62990161 |
| 109 | MP0008874_decreased_physiological_sensi | 0.62490054 |
| 110 | MP0005023_abnormal_wound_healing | 0.61059512 |
| 111 | MP0002139_abnormal_hepatobiliary_system | 0.59972334 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.59138451 |
| 113 | MP0008058_abnormal_DNA_repair | 0.59050270 |
| 114 | MP0008007_abnormal_cellular_replicative | 0.58233568 |
| 115 | MP0003075_altered_response_to | 0.57989175 |
| 116 | MP0005535_abnormal_body_temperature | 0.56583314 |
| 117 | * MP0000313_abnormal_cell_death | 0.56577361 |
| 118 | MP0003045_fibrosis | 0.55737568 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.55552274 |
| 120 | MP0001191_abnormal_skin_condition | 0.52665528 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.51635528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 5.21166444 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.55419841 |
| 3 | Thrombocytosis (HP:0001894) | 4.50915274 |
| 4 | Myositis (HP:0100614) | 4.36790928 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.26230137 |
| 6 | Recurrent viral infections (HP:0004429) | 4.22848231 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.13869003 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.09980519 |
| 9 | Abnormality of the nasal mucosa (HP:0000433) | 4.04092577 |
| 10 | Nasal polyposis (HP:0100582) | 4.00964764 |
| 11 | Petechiae (HP:0000967) | 3.96840517 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.95731308 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.92482274 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.85927103 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.79197741 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.75405793 |
| 17 | IgM deficiency (HP:0002850) | 3.71782622 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.58309432 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.56433056 |
| 20 | Epistaxis (HP:0000421) | 3.50419328 |
| 21 | Abnormal platelet function (HP:0011869) | 3.49791059 |
| 22 | Impaired platelet aggregation (HP:0003540) | 3.49791059 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.48970059 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.48970059 |
| 25 | Stomatitis (HP:0010280) | 3.34163046 |
| 26 | Colitis (HP:0002583) | 3.22764418 |
| 27 | Recurrent skin infections (HP:0001581) | 3.22017402 |
| 28 | Gingival bleeding (HP:0000225) | 3.19928084 |
| 29 | Inflammation of the large intestine (HP:0002037) | 3.19028466 |
| 30 | Orchitis (HP:0100796) | 3.18882269 |
| 31 | Vasculitis (HP:0002633) | 3.16902766 |
| 32 | Cellulitis (HP:0100658) | 3.16783046 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.16218169 |
| 34 | Abnormality of T cells (HP:0002843) | 3.16154700 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.15226773 |
| 36 | Gastrointestinal inflammation (HP:0004386) | 3.13404915 |
| 37 | Abnormality of the fingertips (HP:0001211) | 3.13381538 |
| 38 | Pustule (HP:0200039) | 3.12828536 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.08311412 |
| 40 | Meningitis (HP:0001287) | 3.06812067 |
| 41 | Spontaneous hematomas (HP:0007420) | 3.05448632 |
| 42 | Optic neuritis (HP:0100653) | 3.01806028 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 3.01806028 |
| 44 | T lymphocytopenia (HP:0005403) | 3.00270279 |
| 45 | Abnormality of T cell number (HP:0011839) | 3.00139291 |
| 46 | Chronic sinusitis (HP:0011109) | 2.90999900 |
| 47 | Urticaria (HP:0001025) | 2.82391086 |
| 48 | Gastrointestinal stroma tumor (HP:0100723) | 2.80835072 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.77490223 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.73620334 |
| 51 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.72156979 |
| 52 | Increased IgE level (HP:0003212) | 2.71400215 |
| 53 | Arterial thrombosis (HP:0004420) | 2.70930550 |
| 54 | Lymphopenia (HP:0001888) | 2.70301042 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.67150312 |
| 56 | Periodontitis (HP:0000704) | 2.62365028 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.61489430 |
| 58 | Leukocytosis (HP:0001974) | 2.60703141 |
| 59 | Increased IgM level (HP:0003496) | 2.59268169 |
| 60 | B lymphocytopenia (HP:0010976) | 2.54291035 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.54291035 |
| 62 | Thyroiditis (HP:0100646) | 2.51213110 |
| 63 | Granulocytopenia (HP:0001913) | 2.49669009 |
| 64 | Purpura (HP:0000979) | 2.49448446 |
| 65 | IgG deficiency (HP:0004315) | 2.48054790 |
| 66 | Encephalitis (HP:0002383) | 2.47803613 |
| 67 | Hemoptysis (HP:0002105) | 2.45193695 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44948145 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.38745236 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.38401512 |
| 71 | Emphysema (HP:0002097) | 2.38119698 |
| 72 | Chronic diarrhea (HP:0002028) | 2.37973221 |
| 73 | Albinism (HP:0001022) | 2.37516115 |
| 74 | Abnormal platelet volume (HP:0011876) | 2.37316000 |
| 75 | Verrucae (HP:0200043) | 2.37219594 |
| 76 | Papilloma (HP:0012740) | 2.37219594 |
| 77 | Hematochezia (HP:0002573) | 2.35218734 |
| 78 | Eosinophilia (HP:0001880) | 2.33993299 |
| 79 | Pulmonary embolism (HP:0002204) | 2.33744284 |
| 80 | Menorrhagia (HP:0000132) | 2.32788551 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.32241748 |
| 82 | Amaurosis fugax (HP:0100576) | 2.31017142 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.30634500 |
| 84 | Microcytic anemia (HP:0001935) | 2.30090368 |
| 85 | Chest pain (HP:0100749) | 2.29540900 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.28314299 |
| 87 | Osteomyelitis (HP:0002754) | 2.25977438 |
| 88 | Abnormality of the prostate (HP:0008775) | 2.25740506 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.24647802 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.22940145 |
| 91 | Sepsis (HP:0100806) | 2.22134239 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.21987037 |
| 93 | Restrictive lung disease (HP:0002091) | 2.21240881 |
| 94 | Acute myeloid leukemia (HP:0004808) | 2.21121939 |
| 95 | IgA deficiency (HP:0002720) | 2.21116013 |
| 96 | Bronchitis (HP:0012387) | 2.20562426 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19767689 |
| 98 | Loss of speech (HP:0002371) | 2.19566904 |
| 99 | Combined immunodeficiency (HP:0005387) | 2.19341071 |
| 100 | Recurrent sinusitis (HP:0011108) | 2.18701050 |
| 101 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18580601 |
| 102 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18580601 |
| 103 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18580601 |
| 104 | Skin rash (HP:0000988) | 2.18498988 |
| 105 | Abnormal number of erythroid precursors (HP:0012131) | 2.17874069 |
| 106 | Fatigue (HP:0012378) | 2.17311002 |
| 107 | Skin ulcer (HP:0200042) | 2.17044287 |
| 108 | Increased cerebral lipofuscin (HP:0011813) | 2.16002015 |
| 109 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.15719523 |
| 110 | Poikilocytosis (HP:0004447) | 2.13005742 |
| 111 | Keratoconjunctivitis (HP:0001096) | 2.12629217 |
| 112 | Hepatosplenomegaly (HP:0001433) | 2.12460948 |
| 113 | Hypochromic anemia (HP:0001931) | 2.11393788 |
| 114 | Recurrent lower respiratory tract infections (HP:0002783) | 2.11253210 |
| 115 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10139470 |
| 116 | Obstructive lung disease (HP:0006536) | 2.10139470 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 2.09857568 |
| 118 | Increased serum ferritin (HP:0003281) | 2.09449627 |
| 119 | Lymphoma (HP:0002665) | 2.08874824 |
| 120 | Recurrent pneumonia (HP:0006532) | 2.05905808 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 2.03733547 |
| 122 | Polygenic inheritance (HP:0010982) | 2.03547665 |
| 123 | Viral hepatitis (HP:0006562) | 2.03414411 |
| 124 | Amyloidosis (HP:0011034) | 2.03196081 |
| 125 | Gingivitis (HP:0000230) | 2.01542367 |
| 126 | Reticulocytopenia (HP:0001896) | 2.01418647 |
| 127 | Papilledema (HP:0001085) | 2.01202399 |
| 128 | Episodic fever (HP:0001954) | 1.99132884 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 1.95580773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.27998016 |
| 2 | TYK2 | 3.33429710 |
| 3 | KIT | 3.11201326 |
| 4 | JAK3 | 2.96157520 |
| 5 | IKBKE | 2.87859046 |
| 6 | MAP3K14 | 2.71739652 |
| 7 | TBK1 | 2.65159384 |
| 8 | PRPF4B | 2.58925840 |
| 9 | TXK | 2.42430455 |
| 10 | MAP3K13 | 2.39468614 |
| 11 | TGFBR2 | 2.23118851 |
| 12 | JAK1 | 2.10207337 |
| 13 | IRAK4 | 2.07139862 |
| 14 | FGFR4 | 2.05978986 |
| 15 | BTK | 2.03632867 |
| 16 | ZAP70 | 1.98774316 |
| 17 | IKBKB | 1.93583624 |
| 18 | EEF2K | 1.92291670 |
| 19 | IRAK3 | 1.86939352 |
| 20 | SYK | 1.84712075 |
| 21 | BLK | 1.82684334 |
| 22 | TEC | 1.79512514 |
| 23 | TAOK3 | 1.79004682 |
| 24 | CSF1R | 1.77087000 |
| 25 | TGFBR1 | 1.65503740 |
| 26 | TIE1 | 1.64631367 |
| 27 | FLT3 | 1.52453305 |
| 28 | ERN1 | 1.51861859 |
| 29 | STK10 | 1.46724363 |
| 30 | NME2 | 1.37058411 |
| 31 | LCK | 1.33515495 |
| 32 | MAP3K11 | 1.32173523 |
| 33 | MAP2K3 | 1.29282674 |
| 34 | FGFR3 | 1.27446062 |
| 35 | HCK | 1.24948362 |
| 36 | MAP3K3 | 1.23882104 |
| 37 | RIPK4 | 1.23681444 |
| 38 | GRK6 | 1.21150152 |
| 39 | PIM1 | 1.19690835 |
| 40 | CHUK | 1.17556594 |
| 41 | EPHB1 | 1.17265625 |
| 42 | ITK | 1.15217563 |
| 43 | TESK2 | 1.14130218 |
| 44 | LRRK2 | 1.13999587 |
| 45 | CSK | 1.12631393 |
| 46 | MATK | 1.11252010 |
| 47 | NLK | 1.09094363 |
| 48 | BMPR2 | 1.07099184 |
| 49 | CDC42BPA | 1.06486951 |
| 50 | LYN | 1.05963548 |
| 51 | MAP3K10 | 1.05522670 |
| 52 | KDR | 1.03124897 |
| 53 | FES | 1.00272067 |
| 54 | FGR | 0.96411662 |
| 55 | JAK2 | 0.96222164 |
| 56 | PRKD2 | 0.95727406 |
| 57 | MAP3K1 | 0.95163900 |
| 58 | SIK2 | 0.94504955 |
| 59 | TAOK1 | 0.92041483 |
| 60 | MAPK7 | 0.89248592 |
| 61 | PKN2 | 0.87948955 |
| 62 | RPS6KA4 | 0.85585335 |
| 63 | MAPK12 | 0.82231613 |
| 64 | MARK2 | 0.80834493 |
| 65 | RPS6KB2 | 0.77774395 |
| 66 | MAP3K7 | 0.76807952 |
| 67 | EPHA3 | 0.76651406 |
| 68 | PIK3CG | 0.75023068 |
| 69 | MAP3K6 | 0.74848349 |
| 70 | SMG1 | 0.74075167 |
| 71 | PIM2 | 0.71707955 |
| 72 | TAOK2 | 0.71299989 |
| 73 | STK4 | 0.70529562 |
| 74 | MUSK | 0.69057664 |
| 75 | CLK1 | 0.68717795 |
| 76 | PDPK1 | 0.68174173 |
| 77 | TRPM7 | 0.61614627 |
| 78 | MAPK11 | 0.59917791 |
| 79 | PTK6 | 0.59386271 |
| 80 | FYN | 0.59355439 |
| 81 | RIPK1 | 0.58204462 |
| 82 | ACVR1B | 0.57856212 |
| 83 | MAP2K2 | 0.56215204 |
| 84 | HIPK2 | 0.55887629 |
| 85 | RPS6KA6 | 0.52375836 |
| 86 | PTK2B | 0.51275166 |
| 87 | BMX | 0.51087446 |
| 88 | PRKG2 | 0.49953638 |
| 89 | MARK3 | 0.49569236 |
| 90 | MAP2K6 | 0.47980258 |
| 91 | DYRK1B | 0.46529885 |
| 92 | NEK9 | 0.46373343 |
| 93 | CDK4 | 0.46284455 |
| 94 | BRD4 | 0.45900052 |
| 95 | CDK9 | 0.45048085 |
| 96 | SIK3 | 0.44841660 |
| 97 | MAP3K5 | 0.44676823 |
| 98 | YES1 | 0.44670920 |
| 99 | PDK1 | 0.44360708 |
| 100 | GRK7 | 0.44211289 |
| 101 | RPS6KA5 | 0.43345456 |
| 102 | PRKAA2 | 0.41580523 |
| 103 | RPS6KA2 | 0.41575466 |
| 104 | TTN | 0.40215599 |
| 105 | PRKCQ | 0.40060229 |
| 106 | TNK2 | 0.39607523 |
| 107 | IRAK1 | 0.39542880 |
| 108 | CAMKK2 | 0.39505930 |
| 109 | CDK6 | 0.38860287 |
| 110 | CAMK1D | 0.37657339 |
| 111 | MAPKAPK3 | 0.37612860 |
| 112 | RET | 0.37532897 |
| 113 | RPS6KC1 | 0.36689453 |
| 114 | RPS6KL1 | 0.36689453 |
| 115 | MAPKAPK5 | 0.36148406 |
| 116 | MAPK4 | 0.35861275 |
| 117 | EIF2AK1 | 0.33463366 |
| 118 | PRKD1 | 0.32927950 |
| 119 | ADRBK2 | 0.32323004 |
| 120 | ATR | 0.32021416 |
| 121 | MAPK3 | 0.31435825 |
| 122 | CDK12 | 0.31145284 |
| 123 | MAPKAPK2 | 0.30849139 |
| 124 | EIF2AK2 | 0.30835217 |
| 125 | TRIB3 | 0.30431992 |
| 126 | DAPK2 | 0.29963783 |
| 127 | SIK1 | 0.29618127 |
| 128 | PRKCD | 0.29553291 |
| 129 | CDK19 | 0.29069395 |
| 130 | NUAK1 | 0.27615284 |
| 131 | ABL1 | 0.27358979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.79637483 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77986832 |
| 3 | Measles_Homo sapiens_hsa05162 | 2.75291768 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73999283 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.64425147 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.61890491 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.51621952 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39646397 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.33664802 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.28786627 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24736575 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23291664 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.15342118 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12014979 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.94174467 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.86356506 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77733753 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76893373 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.75457951 |
| 20 | Ribosome_Homo sapiens_hsa03010 | 1.60472452 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57673806 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.56214838 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51858260 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50709511 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.45762531 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45034680 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.43404155 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.42923062 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.42283417 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39435166 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.39036901 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35151462 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.30648821 |
| 34 | DNA replication_Homo sapiens_hsa03030 | 1.28055118 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27629634 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25919988 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.24787679 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24337829 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.24064698 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.23740302 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23102625 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21172007 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17906393 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.17245719 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14743290 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.03721341 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.02059771 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 1.02029241 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00049467 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.96806152 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96475465 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93596769 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88334714 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87207602 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86849439 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86294976 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84527316 |
| 58 | Mismatch repair_Homo sapiens_hsa03430 | 0.82310584 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80089284 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80079023 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79441570 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.79287843 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76609551 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76554678 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76008986 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74441075 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71945526 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71851399 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70623745 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67119745 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66101510 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65095802 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64208394 |
| 74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60293867 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58248619 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57423574 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56711936 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.56012664 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54784506 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.54189847 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53350058 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52671494 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52224097 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51532068 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.50280717 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.50091345 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48541568 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.46397140 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45161333 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44347266 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43195254 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42550436 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41592780 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41432846 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40289531 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39891345 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38154990 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38027525 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35256796 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33673194 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33454956 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32715648 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31324473 |
| 104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31268308 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30647001 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29835549 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29573077 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27672703 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26997106 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26839703 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26693255 |
| 112 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25086391 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24696569 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24068085 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23934980 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23559073 |
| 117 | RNA degradation_Homo sapiens_hsa03018 | 0.22892183 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22726750 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21901700 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21293285 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.21168318 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.21084570 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.20665622 |
| 124 | Spliceosome_Homo sapiens_hsa03040 | 0.20269304 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18549385 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16726755 |

